Cubist Pharmaceuticals Inc (CBST) announced yesterday, it is recalling 101 production lots of its antibiotic Cubicin (daptomycin injection) amid fear of glass particles being present in the drug. Cubicin, which is intravenously administered, is used to treat blood and skin infections. Cubist Pharmaceuticals Inc. (NASDAQ:CBST) belongs to Healthcare sector. Its net profit margin is 0.70% and weekly performance is 0.58%. On last trading day company shares ended up $62.23. Cubist Pharmaceuticals Inc. (NASDAQ:CBST) distance from 50-day simple moving average (SMA50) is -6.68%.

Cempra Holdings (NASDAQ:CEMP) announced its earnings results on Tuesday. The company reported ($0.49) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.56) by $0.07. Cempra, Inc. (NASDAQ:CEMP) shares increased 3.04% in last trading session and ended the day at $10.16. CEMP return on assets is -69.00%. Cempra, Inc. (NASDAQ:CEMP) quarterly performance is 11.28%.

Meridian Interstate Bancorp, Inc. (the “Company”) (Nasdaq:EBSB), the holding company for East Boston Savings Bank, announced today the results of the stock offering of Meridian Bancorp, Inc., a newly formed corporation (“New Meridian”) that is the proposed successor holding company for East Boston Savings Bank. The closing of the offering and the conversion from the mutual holding company to stock holding company form of organization is expected to occur on July 28, 2014.On 11 August, Meridian Bancorp, Inc. (NASDAQ:EBSB) shares increased 1.13% and was closed at $10.75. EBSB EPS growth in last 5 year was 56.00%. Meridian Bancorp, Inc. (NASDAQ:EBSB) year to date (YTD) performance is 16.59%.

On June 30,2014 Point.360 (NASDAQ:PTSX), a leading provider of integrated media management services, today announced the receipt of $1.6 million from the sale of real estate. Point.360 (NASDAQ:PTSX) ended the last trading day at $0.70. Company weekly volatility is calculated as 9.07%and price to cash ratio as 5.71. Point.360 (NASDAQ:PTSX) showed a weekly performance of 7.65%.

Taminco Corp (NYSE:TAM)‘s stock had its “neutral” rating restated by equities researchers at JPMorgan Chase & Co. in a research report issued on Friday.  Taminco Corporation (NYSE:TAM) shares increased 0.64% in last trading session and ended the day on $21.87. TAM Gross Margin is 17.50% and its return on assets is -0.30%. Taminco Corporation (NYSE:TAM) quarterly performance is 5.35%.